The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Determination of the optimal cutoff percentage of residual tumors to define the pathologic response rate (pathRR) of gastric cancer (GC) treated with preoperative therapy (JCOG1004-A).
Kenichi Nakamura
No relevant relationships to disclose
Takeshi Kuwata
No relevant relationships to disclose
Tadakazu Shimoda
No relevant relationships to disclose
Junki Mizusawa
No relevant relationships to disclose
Hiroshi Katayama
No relevant relationships to disclose
Ryoji Kushima
No relevant relationships to disclose
Hirokazu Taniguchi
No relevant relationships to disclose
Hitoshi Katai
No relevant relationships to disclose
Takaki Yoshikawa
No relevant relationships to disclose
Hiroshi Yabusaki
No relevant relationships to disclose
Yoshiyuki Kawashima
No relevant relationships to disclose
Ryohei Kawabata
No relevant relationships to disclose
Norimasa Fukushima
No relevant relationships to disclose
Yoshiaki Iwasaki
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose
Taira Kinoshita
No relevant relationships to disclose
Takeshi Sano
No relevant relationships to disclose
Mitsuru Sasako
No relevant relationships to disclose
Haruhiko Fukuda
No relevant relationships to disclose